PlainPharmaWatch

CMS Open Payments · Program Year 2024

Nielsen BioSciences, Inc.

Nielsen BioSciences, Inc. reported $3,313,138.65 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 24 transactions.

$3.3M Top quartile payer
All-tracks total
24 Below-median volume
Transactions
0 —
Recipients
#341
of 1,925 companies

Nielsen BioSciences, Inc. reported $3,313,138.65 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #341 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Nielsen BioSciences, Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

26/100

Total payments

F

41/100

Transaction volume

F

10/100

Physician reach and Payment type diversity not applicable for Nielsen BioSciences, Inc. - no recorded activity on that dimension; its weight was redistributed to the applicable dimensions above.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer nielsen-biosciences-inc Nielsen BioSciences, Inc.

$3.3M · #341/1,925 · 0.0% industry · PY2024

  • TOT $3.3M
  • RANK #341
  • SHARE 0.0%
  • TXN 24
  • RCP 0
  • CAT 0
  • GEN n/a
  • PY 2024

Nearest volume peer: Paratek Pharmaceuticals, Inc. ($3.3M)

Merit Medical Systems Inc$3.3MBiotissue Holdings Inc.$3.3MParatek Pharmaceuticals, Inc.$3.3MNielsen BioSciences, Inc. (t…$3.3MLEO Pharma Inc.$3.3M
All-tracks payment totals near Nielsen BioSciences, Inc. (CMS Open Payments PY2024)

Nielsen BioSciences, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Nielsen BioSciences, Inc.

CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Nielsen BioSciences, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Nielsen BioSciences, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Nielsen BioSciences, Inc. ranks #341 of 1,925 by all-tracks total payments.

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Nielsen BioSciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.